Prolactin, cortisol, and antidepressant treatment.

Area of Science:

• Neuroendocrinology
• Psychiatry
• Pharmacology

Background:

• Depression is associated with neuroendocrine abnormalities.
• The dexamethasone suppression test (DST) is a biological marker used in depression.
• Plasma prolactin levels can be influenced by antidepressant medications.

Purpose of the Study:

• To investigate the relationship between dexamethasone suppression test (DST) results and plasma prolactin levels following amitriptyline therapy in depressed patients.
• To determine if DST status predicts changes in prolactin levels during antidepressant treatment.

Main Methods:

• Four depressed patients with abnormal DST results and five with normal DST results were treated with amitriptyline.
• Plasma prolactin levels were measured before and after successful amitriptyline therapy.
• Comparison of prolactin level changes based on initial DST findings.

Main Results:

• A significant increase in plasma prolactin levels was observed in the four depressed patients with abnormal DST results after amitriptyline treatment.
• No significant increase in plasma prolactin levels was observed in the five depressed patients with normal DST results after amitriptyline treatment.

Conclusions:

• Successful amitriptyline therapy may lead to increased plasma prolactin levels specifically in depressed patients with abnormal DST findings.
• DST status might be a predictor of prolactin level response to amitriptyline in depression.
• These findings suggest distinct neuroendocrine profiles in subgroups of depressed patients.